Parkinson’s Medication Side Effects: New Study Highlights Differences Between Benserazide and Carbidopa

A new study has shed light on how two common medications used with levodopa—benserazide and carbidopa—may contribute differently to motor complications in people with Parkinson’s disease. What’s the Issue? Levodopa is the gold-standard treatment for Parkinson’s disease, helping to replenish dopamine and improve movement. However, over time, many patients experience side effects like uncontrolled movements (dyskinesia), sudden freezing episodes, and fluctuations in how well the medication works. To help the body absorb levodopa more effectively, it is usually combined with either benserazide or carbidopa. But until now, it was unclear whether one of these additives might lead to more motor complications than the other. What Did the Study Find? Researchers analysed over 8,700 reports of motor complications related to Parkinson’s medications using a U.S. database of drug side effects. They found key differences: Benserazide was more strongly linked to dyskinesia (uncontrolled movements) and the "on-off" phenomenon, where the medication unpredictably stops working and then starts again. Carbidopa was more associated with “wearing-off”, meaning its effects faded more quickly, requiring more frequent doses. What Does This Mean for Patients? This research suggests that the choice between benserazide and carbidopa could impact the type of motor side effects a patient might experience. While both medications help make levodopa more effective, some people may benefit more from one than the other. Future research may help doctors tailor treatment plans to minimise side effects based on an individual’s needs. For now, patients experiencing motor fluctuations should speak with their healthcare provider about their medication regimen and possible adjustments.